(Another) New Drug Approved For Migraine Prevention

Ajovy is first anti-CGRP treatment available at monthly and quarterly doses 

The third new generation of CGRP antibody has been approved. It’s called Emgality (galcanezumab) which was just approved by the FDA on September 27th.

 

·         Watch this interview preview with Professor Lars Edvinsson, the inventor of the CGRP monoclonal antibodies.

 

·         Watch this interview preview with Professor Lars Edvinsson, the inventor of the CGRP monoclonal antibodies.

(2018-09-14)

Read the article in MigraineAgain.com >>>

 

Readers Comments


Comments are closed.

(Another) New Drug Approved For Migraine Prevention

Ajovy is first anti-CGRP treatment available at monthly and quarterly doses 

The third new generation of CGRP antibody has been approved. It’s called Emgality (galcanezumab) which was just approved by the FDA on September 27th.

 

·         Watch this interview preview with Professor Lars Edvinsson, the inventor of the CGRP monoclonal antibodies.

 

·         Watch this interview preview with Professor Lars Edvinsson, the inventor of the CGRP monoclonal antibodies.

(2018-09-14)

Read the article in MigraineAgain.com >>>

 

backtotop